Free Trial

Teradyne (TER) Financials

Teradyne logo
$74.06 +0.20 (+0.27%)
Closing price 04:00 PM Eastern
Extended Trading
$72.72 -1.34 (-1.80%)
As of 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Annual Income Statements for Teradyne

Annual Income Statements for Teradyne

This table shows Teradyne's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Net Income / (Loss) Attributable to Common Shareholders
206 -43 258 452 467 784 1,015 716 449 542
Consolidated Net Income / (Loss)
206 -43 258 452 467 784 1,015 716 449 542
Net Income / (Loss) Continuing Operations
206 -43 258 452 467 784 1,015 716 449 542
Total Pre-Tax Income
253 -55 524 468 526 901 1,161 840 526 609
Total Operating Income
243 -63 525 474 554 928 1,201 832 501 594
Total Gross Profit
916 959 1,221 1,220 1,340 1,786 2,207 1,867 1,537 1,649
Total Revenue
1,640 1,753 2,137 2,101 2,295 3,121 3,703 3,155 2,676 2,820
Operating Revenue
1,640 1,753 2,137 2,101 2,295 3,121 3,703 3,155 2,676 2,820
Total Cost of Revenue
724 795 915 880 955 1,336 1,496 1,288 1,140 1,171
Operating Cost of Revenue
724 795 915 880 955 1,336 1,496 1,288 1,140 1,171
Total Operating Expenses
673 1,022 696 747 786 857 1,006 1,035 1,036 1,055
Selling, General & Admin Expense
306 317 349 391 437 465 548 558 577 617
Research & Development Expense
292 292 307 302 323 375 428 441 418 461
Amortization Expense
69 53 31 39 40 31 21 19 19 19
Other Operating Expenses / (Income)
- - - - - - - 0.00 0.00 -57
Restructuring Charge
5.08 22 9.36 15 -14 -13 9.31 17 21 16
Total Other Income / (Expense), net
10 7.91 -0.93 -6.00 -28 -27 -40 8.45 25 15
Interest Expense
1.88 3.64 22 22 22 24 18 3.72 3.81 3.59
Interest & Investment Income
7.21 9.30 18 20 17 5.98 2.63 6.38 27 25
Other Income / (Expense), net
4.82 2.25 2.93 -4.67 -23 -9.19 -25 5.79 0.96 -5.89
Income Tax Expense
47 -12 267 16 58 117 146 125 77 60
Other Gains / (Losses), net
- - - - - - - 0.00 0.00 -7.21
Basic Earnings per Share
$0.98 ($0.21) $1.30 $2.41 $2.74 $4.72 $6.15 $4.52 $2.91 $3.41
Weighted Average Basic Shares Outstanding
211.54M 202.58M 198.07M 187.67M 170.43M 166.12M 164.96M 158.43M 154.31M 159.08M
Diluted Earnings per Share
$0.97 ($0.21) $1.28 $2.35 $2.60 $4.28 $5.53 $4.22 $2.73 $3.32
Weighted Average Diluted Shares Outstanding
213.32M 202.58M 201.64M 192.61M 179.46M 183.04M 183.63M 169.73M 164.30M 163.31M
Weighted Average Basic & Diluted Shares Outstanding
210.70M 206.80M 198.20M 173.63M 166.78M 166.69M 162.42M 156.05M 153.08M 161.72M
Cash Dividends to Common per Share
$0.24 $0.24 $0.28 $0.36 $0.09 $0.10 $0.40 $0.44 $0.44 $0.48

Quarterly Income Statements for Teradyne

This table shows Teradyne's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Net Income / (Loss) Attributable to Common Shareholders
183 172 84 120 128 117 64 186 146 146
Consolidated Net Income / (Loss)
183 172 84 120 128 117 64 186 146 146
Net Income / (Loss) Continuing Operations
183 172 84 120 128 117 64 186 146 146
Total Pre-Tax Income
226 195 97 144 144 140 73 219 159 158
Total Operating Income
232 167 93 140 144 124 78 210 152 154
Total Gross Profit
485 420 356 402 398 380 339 426 437 447
Total Revenue
827 732 618 684 704 671 600 730 737 753
Operating Revenue
827 732 618 684 704 671 600 730 737 753
Total Cost of Revenue
342 311 261 282 305 291 261 304 301 306
Operating Cost of Revenue
342 311 261 282 305 291 261 304 301 306
Total Operating Expenses
254 254 264 263 254 255 262 215 284 294
Selling, General & Admin Expense
136 143 151 146 138 142 149 154 158 156
Research & Development Expense
112 109 106 106 104 102 103 112 117 128
Amortization Expense
4.73 4.67 4.80 4.83 4.72 4.65 4.70 4.66 4.75 4.66
Restructuring Charge
1.80 -2.37 2.04 6.36 6.86 6.03 4.43 2.01 4.58 4.55
Total Other Income / (Expense), net
-5.31 29 4.22 4.49 0.31 15 -4.87 9.04 6.92 4.21
Interest Expense
0.78 1.02 0.99 1.05 0.96 0.81 0.66 1.53 0.81 0.59
Interest & Investment Income
1.32 3.41 5.26 6.35 6.87 8.86 7.87 6.72 5.08 5.11
Other Income / (Expense), net
-5.85 26 -0.05 -0.82 -5.60 7.43 -12 3.85 2.65 -0.31
Income Tax Expense
43 23 14 24 16 23 8.71 33 12 5.41
Basic Earnings per Share
$1.17 $1.11 $0.54 $0.78 $0.83 $0.76 $0.42 $1.18 $0.89 $0.92
Weighted Average Basic Shares Outstanding
156.36M 158.43M 155.90M 154.76M 153.76M 154.31M 153.05M 157.80M 163.00M 159.08M
Diluted Earnings per Share
$1.10 $1.04 $0.50 $0.73 $0.78 $0.72 $0.40 $1.14 $0.89 $0.89
Weighted Average Diluted Shares Outstanding
166.73M 169.73M 166.31M 164.75M 164.05M 164.30M 162.35M 163.47M 164.25M 163.31M
Weighted Average Basic & Diluted Shares Outstanding
155.76M 156.05M 155.04M 154.01M 152.88M 153.08M 156.11M 163.18M 162.86M 161.72M

Annual Cash Flow Statements for Teradyne

This table details how cash moves in and out of Teradyne's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Net Change in Cash & Equivalents
-30 43 122 497 -153 140 208 -267 -97 -204
Net Cash From Operating Activities
423 455 626 477 579 869 1,098 578 585 672
Net Cash From Continuing Operating Activities
423 455 626 477 579 869 1,098 578 585 672
Net Income / (Loss) Continuing Operations
206 -43 258 452 467 784 1,015 716 449 542
Consolidated Net Income / (Loss)
206 -43 258 452 467 784 1,015 716 449 542
Depreciation Expense
68 65 66 67 71 80 91 91 92 101
Amortization Expense
90 52 35 42 50 57 34 -5.67 19 14
Non-Cash Adjustments To Reconcile Net Income
43 380 39 49 71 56 82 89 73 37
Changes in Operating Assets and Liabilities, net
15 1.93 228 -134 -80 -108 -123 -311 -47 -22
Net Cash From Investing Activities
-114 -640 -263 923 -157 -570 120 44 -180 -622
Net Cash From Continuing Investing Activities
-114 -640 -263 923 -157 -570 120 44 -180 -622
Purchase of Property, Plant & Equipment
-90 -85 -105 -114 -135 -185 -132 -163 -160 -730
Purchase of Investments
-1,424 -1,656 -1,392 -919 -663 -900 -662 -287 -162 -46
Sale of Property, Plant & Equipment
- - - - - 0.00 0.00 3.41 0.00 0.00
Divestitures
- - - - - - - 0.00 0.00 90
Sale and/or Maturity of Investments
1,676 1,096 1,229 2,117 718 515 927 491 146 62
Other Investing Activities, net
6.50 5.05 5.06 9.05 2.91 0.55 0.00 0.00 -4.54 0.87
Net Cash From Financing Activities
-339 228 -245 -903 -574 -158 -1,009 -893 -502 -252
Net Cash From Continuing Financing Activities
-339 228 -245 -903 -574 -158 -1,009 -893 -502 -252
Repayment of Debt
-2.25 - - - 0.00 0.00 -343 -67 -50 -185
Repurchase of Common Equity
-300 -146 -200 -823 -500 -88 -600 -752 -397 -199
Payment of Dividends
-51 -49 -55 -67 -61 -66 -66 -70 -68 -76
Issuance of Debt
- 451 - - - - - 0.00 0.00 185
Issuance of Common Equity
20 88 24 21 29 29 33 29 34 37
Other Financing Activities, net
-5.52 -116 -14 -34 -42 -32 -32 -33 -21 -14
Other Net Changes in Cash
- - - - - -0.66 - 3.89 - -2.28
Cash Interest Paid
0.30 0.45 6.45 6.21 6.00 6.44 4.24 1.50 0.30 0.77
Cash Income Taxes Paid
35 40 54 73 81 107 172 193 140 121

Quarterly Cash Flow Statements for Teradyne

This table details how cash moves in and out of Teradyne's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Net Change in Cash & Equivalents
139 144 -206 -36 24 121 -50 -285 88 43
Net Cash From Operating Activities
272 183 19 143 174 249 7.28 216 166 283
Net Cash From Continuing Operating Activities
272 183 19 143 174 249 7.28 216 166 283
Net Income / (Loss) Continuing Operations
183 172 84 120 128 117 64 186 146 146
Consolidated Net Income / (Loss)
183 172 84 120 128 117 64 186 146 146
Depreciation Expense
23 23 23 23 24 23 23 26 26 26
Amortization Expense
4.92 -21 4.93 4.65 4.50 4.69 4.77 4.38 4.99 0.28
Non-Cash Adjustments To Reconcile Net Income
27 20 22 17 26 7.74 33 -36 9.98 30
Changes in Operating Assets and Liabilities, net
33 -11 -114 -21 -8.08 96 -118 36 -20 80
Net Cash From Investing Activities
100 -1.69 -95 -27 -28 -30 -24 -481 -50 -67
Net Cash From Continuing Investing Activities
100 -1.69 -95 -27 -28 -30 -24 -481 -50 -67
Purchase of Property, Plant & Equipment
-39 -35 -41 -39 -35 -44 -44 -569 -54 -62
Purchase of Investments
-19 -20 -69 -30 -39 -24 -16 -12 -7.34 -11
Sale and/or Maturity of Investments
158 50 15 42 51 38 35 13 8.62 5.63
Net Cash From Financing Activities
-232 -34 -130 -154 -128 -91 -37 -23 -29 -163
Net Cash From Continuing Financing Activities
-232 -34 -130 -154 -128 -91 -37 -23 -29 -163
Repurchase of Common Equity
-217 -2.08 -93 -135 -119 -51 -22 -8.19 -25 -144
Payment of Dividends
-17 -17 -17 -17 -17 -17 -18 -19 -20 -19
Issuance of Common Equity
12 - 16 0.60 17 0.18 17 4.90 15 0.07
Other Financing Activities, net
-0.21 -0.18 -20 -0.44 -0.28 -0.20 -13 -0.32 -0.40 -0.27

Annual Balance Sheets for Teradyne

This table presents Teradyne's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Total Assets
2,549 2,762 3,110 2,707 2,787 3,652 3,809 3,501 3,487 3,709
Total Current Assets
1,260 1,624 2,270 1,732 1,659 2,415 2,576 2,258 2,162 1,816
Cash & Equivalents
265 308 430 927 774 914 1,122 855 758 553
Short-Term Investments
478 871 1,348 190 137 522 244 40 62 46
Accounts Receivable
211 192 273 291 362 498 551 491 422 471
Inventories, net
154 136 108 154 197 222 243 325 310 298
Prepaid Expenses
92 116 112 171 189 250 406 533 549 429
Other Current Assets
6.19 - - - - 9.25 9.45 14 38 18
Other Current Nonoperating Assets
- - - - - - - 0.00 23 0.00
Plant, Property, & Equipment, net
273 254 268 280 320 395 387 419 445 508
Total Noncurrent Assets
1,015 885 571 694 808 842 846 825 879 1,384
Long-Term Investments
266 434 126 88 104 118 134 111 117 619
Goodwill
488 223 252 382 416 454 426 403 416 395
Intangible Assets
240 100 79 125 125 101 76 53 35 16
Noncurrent Deferred & Refundable Income Taxes
7.40 107 84 71 75 88 102 143 176 222
Employee Benefit Assets
0.64 7.71 17 17 18 17 15 12 12 12
Other Noncurrent Operating Assets
13 12 12 12 68 64 93 103 112 120
Other Noncurrent Nonoperating Assets
- - - - - - - 0.00 12 0.00
Total Liabilities & Shareholders' Equity
2,549 2,762 3,110 2,707 2,787 3,652 3,809 3,501 3,487 3,709
Total Liabilities
583 934 1,156 1,184 1,307 1,442 1,245 1,050 961 889
Total Current Liabilities
373 373 454 476 539 701 805 746 660 625
Accounts Payable
92 95 86 101 127 134 153 140 180 135
Accrued Expenses
44 51 59 78 71 78 124 112 115 91
Current Deferred Revenue
86 84 84 78 105 135 146 148 100 108
Current Deferred & Payable Income Tax Liabilities
22 30 59 36 44 81 89 65 49 68
Current Employee Benefit Liabilities
114 110 142 149 164 220 254 212 192 205
Other Current Liabilities
- - - - 19 21 20 19 18 19
Other Current Nonoperating Liabilities
- - - - - - - 0.00 7.38 0.00
Total Noncurrent Liabilities
210 561 702 708 768 741 440 304 301 265
Long-Term Debt
- 353 366 380 395 377 89 0.00 0.00 0.00
Noncurrent Deferred Revenue
26 23 178 117 129 133 122 104 82 65
Noncurrent Deferred & Payable Income Tax Liabilities
27 12 6.72 21 14 11 6.33 3.27 0.18 1.04
Noncurrent Employee Benefit Liabilities
104 107 120 117 134 151 151 116 132 133
Other Noncurrent Operating Liabilities
54 66 31 73 96 69 72 80 85 65
Other Noncurrent Nonoperating Liabilities
- - - - - - - 0.00 2.00 0.00
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
1,966 1,829 1,954 1,522 1,480 2,207 2,562 2,451 2,526 2,819
Total Preferred & Common Equity
1,966 1,829 1,954 1,522 1,480 2,207 2,562 2,451 2,526 2,819
Total Common Equity
1,966 1,829 1,954 1,522 1,480 2,207 2,562 2,451 2,526 2,819
Common Stock
1,506 1,619 1,663 1,694 1,741 1,786 1,832 1,775 1,846 1,930
Retained Earnings
468 230 272 -158 -242 387 737 726 707 971
Accumulated Other Comprehensive Income / (Loss)
-8.14 -20 19 -13 -19 34 -5.95 -50 -27 -81

Quarterly Balance Sheets for Teradyne

This table presents Teradyne's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Total Assets
3,320 3,501 3,383 3,395 3,371 3,487 3,411 3,632 3,770 3,709
Total Current Assets
2,128 2,258 2,112 2,124 2,099 2,162 2,065 1,756 1,839 1,816
Cash & Equivalents
711 855 649 613 637 758 707 422 510 553
Short-Term Investments
65 40 93 95 80 62 41 39 42 46
Accounts Receivable
530 491 455 493 456 422 426 470 484 471
Inventories, net
311 325 352 347 323 310 314 289 297 298
Prepaid Expenses
503 533 549 561 593 549 538 516 490 429
Other Current Assets
7.72 14 13 14 11 38 16 21 16 18
Other Current Nonoperating Assets
- 0.00 - - - 23 22 0.00 0.00 0.00
Plant, Property, & Equipment, net
415 419 432 437 436 445 457 472 492 508
Total Noncurrent Assets
777 825 839 834 835 879 888 1,403 1,439 1,384
Long-Term Investments
111 111 117 105 104 117 122 648 664 619
Goodwill
376 403 410 412 401 416 408 405 419 395
Intangible Assets
56 53 49 45 39 35 30 25 21 16
Noncurrent Deferred & Refundable Income Taxes
130 143 149 152 163 176 186 193 202 222
Employee Benefit Assets
14 12 12 12 11 12 11 11 13 12
Other Noncurrent Operating Assets
91 103 103 109 117 112 120 120 119 120
Other Noncurrent Nonoperating Assets
- 0.00 - - - 12 11 0.00 0.00 0.00
Total Liabilities & Shareholders' Equity
3,320 3,501 3,383 3,395 3,371 3,487 3,411 3,632 3,770 3,709
Total Liabilities
1,066 1,050 934 960 929 961 853 901 867 889
Total Current Liabilities
702 746 628 670 641 660 554 626 595 625
Accounts Payable
168 140 142 153 176 180 154 161 158 135
Accrued Expenses
126 112 115 114 123 115 101 109 105 91
Current Deferred Revenue
144 148 119 120 109 100 100 103 100 108
Current Deferred & Payable Income Tax Liabilities
64 65 77 65 36 49 56 74 53 68
Current Employee Benefit Liabilities
168 212 119 164 155 192 121 161 160 205
Other Current Liabilities
17 19 20 20 18 18 17 18 19 19
Other Current Nonoperating Liabilities
- 0.00 - - - 7.38 4.69 0.00 0.00 0.00
Total Noncurrent Liabilities
364 304 306 290 289 301 299 275 272 265
Long-Term Debt
50 0.00 - - - 0.00 - - - 0.00
Noncurrent Deferred Revenue
108 104 101 83 79 82 79 61 66 65
Noncurrent Deferred & Payable Income Tax Liabilities
1.33 3.27 2.33 1.30 0.24 0.18 0.13 0.10 0.16 1.04
Noncurrent Employee Benefit Liabilities
137 116 121 124 123 132 135 135 138 133
Other Noncurrent Operating Liabilities
67 80 81 82 86 85 82 79 69 65
Other Noncurrent Nonoperating Liabilities
- 0.00 - - - 2.00 1.94 0.00 0.00 0.00
Commitments & Contingencies
0.00 0.00 0.00 - 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
2,254 2,451 2,449 2,435 2,441 2,526 2,558 2,731 2,903 2,819
Total Preferred & Common Equity
2,254 2,451 2,449 2,435 2,441 2,526 2,558 2,731 2,903 2,819
Total Common Equity
2,254 2,451 2,449 2,435 2,441 2,526 2,558 2,731 2,903 2,819
Common Stock
1,766 1,775 1,792 1,804 1,835 1,846 1,867 1,886 1,917 1,930
Retained Earnings
573 726 694 661 654 707 730 889 990 971
Accumulated Other Comprehensive Income / (Loss)
-85 -50 -36 -30 -48 -27 -40 -44 -4.03 -81

Annual Metrics and Ratios for Teradyne

This table displays calculated financial ratios and metrics derived from Teradyne's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Growth Metrics
- - - - - - - - - -
Revenue Growth
-0.50% 6.93% 21.87% -1.68% 9.24% 36.01% 18.63% -14.79% -15.17% 5.36%
EBITDA Growth
37.65% -86.20% 1,022.76% -8.05% 12.54% 62.08% 23.23% -29.10% -33.58% 14.74%
EBIT Growth
157.97% -124.50% 970.02% -11.20% 13.19% 73.11% 27.95% -28.77% -40.07% 17.10%
NOPAT Growth
141.22% -122.24% 685.65% 77.25% 7.58% 64.14% 29.87% -32.50% -39.60% 25.23%
Net Income Growth
154.06% -121.03% 693.47% 75.32% 3.47% 67.74% 29.39% -29.48% -37.28% 20.86%
EPS Growth
162.16% -121.65% 709.52% 83.59% 10.64% 64.62% 29.21% -23.69% -35.31% 21.61%
Operating Cash Flow Growth
-14.02% 7.59% 37.63% -23.88% 21.36% 50.14% 26.40% -47.38% 1.26% 14.86%
Free Cash Flow Firm Growth
-97.70% 5,621.09% 7.83% -57.32% 115.72% 70.95% 54.80% -59.30% -6.10% 38.08%
Invested Capital Growth
24.57% -41.45% -22.69% 66.36% 18.51% 22.84% 9.90% 27.66% 4.48% 2.41%
Revenue Q/Q Growth
-0.29% 3.64% 4.88% 1.95% 6.25% 3.46% 3.52% -4.63% -2.24% 3.01%
EBITDA Q/Q Growth
26.92% 193.57% 6.55% 3.48% 7.26% 8.78% 1.52% -9.13% -9.04% 2.98%
EBIT Q/Q Growth
88.77% 52.65% 8.10% 3.30% 7.96% 9.19% 2.49% -7.12% -10.85% 3.80%
NOPAT Q/Q Growth
107.95% 51.16% -40.17% 125.75% -0.03% 8.23% 1.85% -9.83% -9.23% 9.09%
Net Income Q/Q Growth
99.87% 60.67% -40.07% 123.58% -3.85% 10.00% 2.81% -6.74% -10.96% 5.69%
EPS Q/Q Growth
97.96% 61.82% -40.47% 123.81% -3.35% 9.46% 4.14% -5.17% -10.49% 5.40%
Operating Cash Flow Q/Q Growth
-22.73% -2.83% 21.35% 8.88% 5.46% 5.35% 6.90% -20.37% 12.58% 5.29%
Free Cash Flow Firm Q/Q Growth
-95.36% 2.88% 23.13% 77.30% -12.56% 15.50% 10.65% -34.84% 39.42% 10.95%
Invested Capital Q/Q Growth
0.47% 7.68% -31.81% -3.00% 3.38% 0.76% -5.16% 4.50% -4.93% -5.07%
Profitability Metrics
- - - - - - - - - -
Gross Margin
55.85% 54.68% 57.17% 58.09% 58.38% 57.21% 59.59% 59.18% 57.42% 58.48%
EBITDA Margin
24.78% 3.20% 29.47% 27.56% 28.40% 33.84% 35.15% 29.25% 22.90% 24.94%
Operating Margin
14.82% -3.59% 24.59% 22.55% 24.12% 29.74% 32.43% 26.37% 18.72% 21.06%
EBIT Margin
15.11% -3.46% 24.72% 22.33% 23.14% 29.45% 31.76% 26.55% 18.76% 20.85%
Profit (Net Income) Margin
12.59% -2.48% 12.06% 21.51% 20.37% 25.12% 27.40% 22.68% 16.77% 19.23%
Tax Burden Percent
81.57% 78.86% 49.14% 96.58% 88.91% 87.03% 87.39% 85.14% 85.38% 89.05%
Interest Burden Percent
102.15% 90.68% 99.27% 99.72% 99.01% 98.02% 98.71% 100.32% 104.69% 103.60%
Effective Tax Rate
18.43% 0.00% 50.86% 3.43% 11.09% 12.97% 12.61% 14.86% 14.62% 9.77%
Return on Invested Capital (ROIC)
22.60% -5.72% 51.12% 78.02% 61.50% 83.52% 93.75% 53.09% 27.97% 33.86%
ROIC Less NNEP Spread (ROIC-NNEP)
21.88% -5.77% 51.15% 78.52% 65.04% 86.24% 96.49% 52.48% 25.78% 33.26%
Return on Net Nonoperating Assets (RNNOA)
-12.39% 3.43% -37.49% -52.02% -30.36% -41.03% -51.25% -24.56% -9.93% -13.57%
Return on Equity (ROE)
10.21% -2.29% 13.63% 25.99% 31.14% 42.49% 42.50% 28.53% 18.03% 20.29%
Cash Return on Invested Capital (CROIC)
0.72% 46.58% 76.71% 28.19% 44.56% 63.02% 84.32% 28.79% 23.58% 31.48%
Operating Return on Assets (OROA)
9.74% -2.29% 17.99% 16.13% 19.33% 28.55% 31.52% 22.92% 14.37% 16.34%
Return on Assets (ROA)
8.12% -1.64% 8.78% 15.54% 17.02% 24.35% 27.19% 19.57% 12.84% 15.08%
Return on Common Equity (ROCE)
10.21% -2.29% 13.63% 25.99% 31.14% 42.45% 42.45% 28.52% 18.03% 20.29%
Return on Equity Simple (ROE_SIMPLE)
10.50% -2.37% 13.19% 29.68% 31.58% 35.53% 39.59% 29.19% 17.77% 19.24%
Net Operating Profit after Tax (NOPAT)
198 -44 258 458 492 808 1,049 708 428 536
NOPAT Margin
12.09% -2.51% 12.08% 21.78% 21.45% 25.88% 28.34% 22.45% 15.99% 19.00%
Net Nonoperating Expense Percent (NNEP)
0.72% 0.06% -0.03% -0.50% -3.54% -2.71% -2.74% 0.61% 2.18% 0.60%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - - 28.32% 16.94% 19.00%
Cost of Revenue to Revenue
44.15% 45.32% 42.83% 41.91% 41.62% 42.79% 40.41% 40.82% 42.58% 41.52%
SG&A Expenses to Revenue
18.68% 18.05% 16.33% 18.60% 19.05% 14.89% 14.79% 17.69% 21.57% 21.88%
R&D to Revenue
17.82% 16.66% 14.38% 14.35% 14.07% 12.01% 11.55% 13.96% 15.62% 16.34%
Operating Expenses to Revenue
41.03% 58.27% 32.58% 35.54% 34.26% 27.47% 27.17% 32.81% 38.70% 37.42%
Earnings before Interest and Taxes (EBIT)
248 -61 528 469 531 919 1,176 838 502 588
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
406 56 630 579 652 1,056 1,302 923 613 703
Valuation Ratios
- - - - - - - - - -
Price to Book Value (P/BV)
2.05 2.68 4.06 3.60 7.58 8.90 10.29 5.50 6.53 7.27
Price to Tangible Book Value (P/TBV)
3.25 3.25 4.89 5.40 11.95 11.88 12.80 6.76 7.95 8.51
Price to Revenue (P/Rev)
2.45 2.79 3.71 2.61 4.89 6.29 7.12 4.27 6.17 7.26
Price to Earnings (P/E)
19.47 0.00 30.76 12.13 23.99 25.04 25.99 18.83 36.78 37.77
Dividend Yield
1.23% 0.99% 0.69% 1.18% 0.54% 0.34% 0.25% 0.51% 0.41% 0.38%
Earnings Yield
5.13% 0.00% 3.25% 8.25% 4.17% 3.99% 3.85% 5.31% 2.72% 2.65%
Enterprise Value to Invested Capital (EV/IC)
3.11 6.38 14.56 6.40 12.21 17.34 21.31 8.37 9.96 12.03
Enterprise Value to Revenue (EV/Rev)
1.85 2.07 3.00 2.23 4.62 5.93 6.75 3.97 5.82 6.83
Enterprise Value to EBITDA (EV/EBITDA)
7.45 64.81 10.19 8.10 16.27 17.51 19.19 13.57 25.40 27.40
Enterprise Value to EBIT (EV/EBIT)
12.22 0.00 12.14 9.99 19.96 20.12 21.24 14.95 31.01 32.77
Enterprise Value to NOPAT (EV/NOPAT)
15.28 0.00 24.85 10.25 21.53 22.89 23.80 17.68 36.39 35.96
Enterprise Value to Operating Cash Flow (EV/OCF)
7.16 7.99 10.24 9.83 18.32 21.28 22.74 21.67 26.60 28.66
Enterprise Value to Free Cash Flow (EV/FCFF)
482.24 10.12 16.56 28.36 29.72 30.34 26.47 32.59 43.16 38.68
Leverage & Solvency
- - - - - - - - - -
Debt to Equity
0.01 0.19 0.20 0.27 0.27 0.19 0.04 0.02 0.00 0.00
Long-Term Debt to Equity
0.00 0.19 0.19 0.25 0.27 0.17 0.03 0.00 0.00 0.00
Financial Leverage
-0.57 -0.59 -0.73 -0.66 -0.47 -0.48 -0.53 -0.47 -0.39 -0.41
Leverage Ratio
1.26 1.40 1.55 1.67 1.83 1.74 1.56 1.46 1.40 1.35
Compound Leverage Factor
1.28 1.27 1.54 1.67 1.81 1.71 1.54 1.46 1.47 1.39
Debt to Total Capital
0.78% 16.21% 16.66% 21.41% 21.43% 15.65% 4.06% 2.00% 0.00% 0.00%
Short-Term Debt to Total Capital
0.78% 0.05% 1.05% 1.80% 0.48% 1.27% 0.72% 2.00% 0.00% 0.00%
Long-Term Debt to Total Capital
0.00% 16.16% 15.61% 19.62% 20.95% 14.38% 3.34% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.14% 0.06% 0.00% 0.00% 0.00%
Common Equity to Total Capital
99.22% 83.79% 83.34% 78.59% 78.57% 84.21% 95.89% 98.00% 100.00% 100.00%
Debt to EBITDA
0.04 6.31 0.62 0.72 0.62 0.39 0.08 0.05 0.00 0.00
Net Debt to EBITDA
-2.44 -22.45 -2.40 -1.36 -0.94 -1.08 -1.07 -1.03 0.00 0.00
Long-Term Debt to EBITDA
0.00 6.29 0.58 0.66 0.61 0.36 0.07 0.00 0.00 0.00
Debt to NOPAT
0.08 -8.02 1.51 0.91 0.82 0.51 0.10 0.07 0.00 0.00
Net Debt to NOPAT
-5.01 28.56 -5.86 -1.73 -1.24 -1.42 -1.33 -1.35 0.00 0.00
Long-Term Debt to NOPAT
0.00 -8.00 1.42 0.83 0.80 0.47 0.09 0.00 0.00 0.00
Altman Z-Score
5.78 4.37 6.19 4.60 6.96 10.57 15.52 10.20 12.35 15.86
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.10% 0.11% 0.03% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - -
Current Ratio
3.38 4.36 5.00 3.64 3.08 3.45 3.20 3.03 3.28 2.91
Quick Ratio
2.56 3.68 4.51 2.96 2.36 2.76 2.38 1.86 1.88 1.71
Cash Flow Metrics
- - - - - - - - - -
Free Cash Flow to Firm (FCFF)
6.28 359 387 165 357 610 944 384 361 498
Operating Cash Flow to CapEx
470.72% 533.82% 594.54% 416.93% 429.84% 469.75% 829.13% 361.57% 366.59% 92.06%
Free Cash Flow to Firm to Interest Expense
3.35 98.78 17.88 7.59 16.05 25.21 52.96 103.30 94.78 138.86
Operating Cash Flow to Interest Expense
225.52 125.16 28.92 21.90 26.04 35.93 61.64 155.40 153.77 187.39
Operating Cash Flow Less CapEx to Interest Expense
177.61 101.71 24.06 16.64 19.98 28.28 54.20 112.42 111.82 -16.16
Efficiency Ratios
- - - - - - - - - -
Asset Turnover
0.64 0.66 0.73 0.72 0.84 0.97 0.99 0.86 0.77 0.78
Accounts Receivable Turnover
9.05 8.69 9.19 7.45 7.02 7.26 7.06 6.06 5.86 6.31
Inventory Turnover
5.60 5.49 7.52 6.74 5.45 6.38 6.43 4.53 3.59 3.85
Fixed Asset Turnover
5.44 6.65 8.18 7.66 7.65 8.73 9.47 7.83 6.19 5.91
Accounts Payable Turnover
10.33 8.47 10.07 9.41 8.40 10.26 10.43 8.80 7.13 7.44
Days Sales Outstanding (DSO)
40.33 42.03 39.74 49.00 51.98 50.27 51.66 60.27 62.28 57.83
Days Inventory Outstanding (DIO)
65.22 66.50 48.56 54.12 66.92 57.23 56.78 80.54 101.69 94.83
Days Payable Outstanding (DPO)
35.32 43.11 36.25 38.78 43.43 35.56 34.98 41.50 51.22 49.08
Cash Conversion Cycle (CCC)
70.23 65.41 52.05 64.34 75.47 71.94 73.46 99.31 112.75 103.58
Capital & Investment Metrics
- - - - - - - - - -
Invested Capital
973 570 440 733 868 1,067 1,172 1,496 1,563 1,601
Invested Capital Turnover
1.87 2.27 4.23 3.58 2.87 3.23 3.31 2.36 1.75 1.78
Increase / (Decrease) in Invested Capital
192 -403 -129 292 136 198 106 324 67 38
Enterprise Value (EV)
3,028 3,635 6,414 4,688 10,601 18,495 24,979 12,521 15,568 19,267
Market Capitalization
4,021 4,894 7,927 5,478 11,212 19,636 26,369 13,476 16,505 20,486
Book Value per Share
$9.57 $9.09 $9.96 $8.49 $8.83 $13.29 $15.72 $15.74 $16.52 $17.31
Tangible Book Value per Share
$6.02 $7.48 $8.27 $5.66 $5.60 $9.95 $12.64 $12.81 $13.57 $14.79
Total Capital
1,981 2,182 2,344 1,937 1,884 2,621 2,672 2,501 2,526 2,819
Total Debt
16 354 390 415 404 410 108 50 0.00 0.00
Total Long-Term Debt
0.00 353 366 380 395 377 89 0.00 0.00 0.00
Net Debt
-993 -1,259 -1,513 -790 -612 -1,144 -1,392 -955 -937 -1,218
Capital Expenditures (CapEx)
90 85 105 114 135 185 132 160 160 730
Debt-free, Cash-free Net Working Capital (DFCFNWC)
160 73 63 174 218 312 424 667 682 592
Debt-free Net Working Capital (DFNWC)
903 1,252 1,840 1,291 1,129 1,748 1,790 1,562 1,502 1,192
Net Working Capital (NWC)
887 1,251 1,816 1,256 1,120 1,715 1,771 1,512 1,502 1,192
Net Nonoperating Expense (NNE)
-8.28 -0.66 0.46 5.79 25 24 35 -7.19 -21 -6.59
Net Nonoperating Obligations (NNO)
-993 -1,259 -1,513 -790 -612 -1,144 -1,392 -955 -963 -1,218
Total Depreciation and Amortization (D&A)
159 117 101 110 121 137 125 85 111 115
Debt-free, Cash-free Net Working Capital to Revenue
9.77% 4.18% 2.93% 8.29% 9.49% 9.98% 11.45% 21.15% 25.50% 21.00%
Debt-free Net Working Capital to Revenue
55.05% 71.42% 86.14% 61.46% 49.19% 56.00% 48.35% 49.50% 56.13% 42.26%
Net Working Capital to Revenue
54.11% 71.36% 84.99% 59.80% 48.80% 54.93% 47.83% 47.91% 56.13% 42.26%
Earnings Adjustments
- - - - - - - - - -
Adjusted Basic Earnings per Share
$0.98 ($0.21) $1.30 $2.41 $2.74 $4.72 $6.15 $4.52 $2.91 $3.41
Adjusted Weighted Average Basic Shares Outstanding
211.54M 202.58M 198.07M 187.67M 170.43M 166.12M 164.96M 158.43M 154.31M 159.08M
Adjusted Diluted Earnings per Share
$0.97 ($0.21) $1.28 $2.35 $2.60 $4.28 $5.53 $4.22 $2.73 $3.32
Adjusted Weighted Average Diluted Shares Outstanding
213.32M 202.58M 201.64M 192.61M 179.46M 183.04M 183.63M 169.73M 164.30M 163.31M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $2.74 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
204.34M 200.30M 195.42M 173.63M 166.78M 166.69M 162.42M 156.05M 153.08M 161.72M
Normalized Net Operating Profit after Tax (NOPAT)
202 208 374 472 480 796 1,057 723 446 550
Normalized NOPAT Margin
12.34% 11.87% 17.52% 22.48% 20.91% 25.52% 28.56% 22.91% 16.66% 19.50%
Pre Tax Income Margin
15.44% -3.14% 24.54% 22.27% 22.91% 28.87% 31.35% 26.64% 19.64% 21.60%
Debt Service Ratios
- - - - - - - - - -
EBIT to Interest Expense
132.08 -16.69 24.39 21.54 23.89 38.01 66.00 225.26 131.90 163.90
NOPAT to Interest Expense
105.65 -12.12 11.92 21.01 22.15 33.41 58.89 190.46 112.41 149.37
EBIT Less CapEx to Interest Expense
84.17 -40.14 19.52 16.29 17.84 30.36 58.57 182.28 89.96 -39.66
NOPAT Less CapEx to Interest Expense
57.74 -35.57 7.05 15.76 16.09 25.76 51.45 147.48 70.46 -54.19
Payout Ratios
- - - - - - - - - -
Dividend Payout Ratio
24.56% -111.97% 21.52% 14.90% 13.11% 8.48% 6.50% 9.74% 15.13% 14.09%
Augmented Payout Ratio
169.83% -448.98% 99.25% 197.18% 120.07% 19.76% 65.64% 114.86% 103.65% 50.70%

Quarterly Metrics and Ratios for Teradyne

This table displays calculated financial ratios and metrics derived from Teradyne's official financial filings.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Growth Metrics
- - - - - - - - - -
Revenue Growth
-12.99% -17.31% -18.25% -18.59% -14.91% -8.37% -2.87% 6.64% 4.77% 12.27%
EBITDA Growth
-23.31% -32.21% -42.22% -37.33% -34.45% -18.11% -22.09% 46.83% 11.26% 12.74%
EBIT Growth
-25.01% -24.99% -48.63% -41.69% -38.68% -31.68% -29.22% 54.01% 11.81% 16.33%
NOPAT Growth
-32.44% -34.70% -52.12% -43.42% -31.92% -29.20% -14.29% 53.55% 9.77% 42.49%
Net Income Growth
-28.53% -23.09% -48.41% -39.30% -30.18% -32.06% -23.15% 55.16% 13.69% 24.94%
EPS Growth
-21.99% -18.11% -45.65% -37.07% -29.09% -30.77% -20.00% 56.16% 14.10% 23.61%
Operating Cash Flow Growth
-48.03% -44.64% 159.13% 23.66% -35.81% 35.65% -62.36% 51.34% -4.63% 13.58%
Free Cash Flow Firm Growth
-108.12% -248.13% -362.25% -132.79% -937.43% 120.89% 119.13% 456.40% 215.84% 199.01%
Invested Capital Growth
15.86% 27.66% 18.86% 11.86% 14.85% 4.48% 2.12% -1.94% 2.57% 2.41%
Revenue Q/Q Growth
-1.63% -11.51% -15.62% 10.83% 2.82% -4.71% -10.55% 21.68% 1.02% 2.11%
EBITDA Q/Q Growth
-4.28% -23.22% -45.41% 38.10% 0.12% -4.08% -41.25% 160.27% -24.13% -2.81%
EBIT Q/Q Growth
-5.41% -14.54% -51.87% 49.86% -0.52% -4.78% -50.14% 226.07% -27.78% -0.93%
NOPAT Q/Q Growth
-8.65% -21.71% -45.65% 45.57% 9.91% -18.58% -34.21% 160.79% -21.42% 5.69%
Net Income Q/Q Growth
-7.23% -6.10% -51.52% 43.72% 6.72% -8.63% -45.16% 190.16% -21.81% 0.41%
EPS Q/Q Growth
-5.17% -5.45% -51.92% 46.00% 6.85% -7.69% -44.44% 185.00% -21.93% 0.00%
Operating Cash Flow Q/Q Growth
135.25% -32.47% -89.46% 638.35% 22.12% 42.69% -97.07% 2,868.39% -23.05% 69.94%
Free Cash Flow Firm Q/Q Growth
-104.53% -2,069.01% -0.47% 66.78% -43.29% 143.68% -7.97% 518.83% -53.43% 12.73%
Invested Capital Q/Q Growth
-3.20% 4.50% 8.64% 1.79% -0.62% -4.93% 6.18% -2.26% 3.95% -5.07%
Profitability Metrics
- - - - - - - - - -
Gross Margin
58.69% 57.45% 57.72% 58.81% 56.60% 56.60% 56.56% 58.34% 59.20% 59.41%
EBITDA Margin
30.71% 26.65% 19.50% 24.30% 23.66% 23.81% 15.64% 33.45% 25.13% 23.91%
Operating Margin
27.99% 22.76% 15.04% 20.44% 20.46% 18.54% 12.97% 28.82% 20.62% 20.40%
EBIT Margin
27.28% 26.35% 15.03% 20.32% 19.66% 19.65% 10.95% 29.35% 20.98% 20.36%
Profit (Net Income) Margin
22.18% 23.54% 13.53% 17.54% 18.21% 17.46% 10.70% 25.52% 19.75% 19.43%
Tax Burden Percent
81.12% 88.25% 86.04% 83.14% 88.80% 83.73% 88.06% 84.90% 91.61% 92.68%
Interest Burden Percent
100.24% 101.24% 104.60% 103.82% 104.27% 106.11% 110.97% 102.42% 102.76% 102.95%
Effective Tax Rate
18.88% 11.75% 13.96% 16.86% 11.20% 16.27% 11.94% 15.10% 7.71% 3.43%
Return on Invested Capital (ROIC)
56.32% 47.51% 26.09% 31.03% 32.33% 27.16% 18.48% 40.38% 31.29% 35.11%
ROIC Less NNEP Spread (ROIC-NNEP)
56.72% 45.35% 25.71% 30.56% 32.30% 25.80% 18.98% 39.57% 30.76% 35.30%
Return on Net Nonoperating Assets (RNNOA)
-25.16% -21.22% -10.08% -10.33% -11.14% -9.94% -6.53% -14.47% -11.59% -14.40%
Return on Equity (ROE)
31.15% 26.28% 16.00% 20.70% 21.19% 17.21% 11.95% 25.92% 19.70% 20.71%
Cash Return on Invested Capital (CROIC)
44.20% 28.79% 24.32% 22.78% 16.82% 23.58% 23.24% 31.16% 26.96% 31.48%
Operating Return on Assets (OROA)
25.49% 22.74% 12.97% 16.89% 16.09% 15.05% 8.57% 22.59% 16.09% 15.96%
Return on Assets (ROA)
20.73% 20.32% 11.67% 14.58% 14.90% 13.37% 8.38% 19.64% 15.15% 15.23%
Return on Common Equity (ROCE)
31.14% 26.28% 16.00% 20.70% 21.19% 17.21% 11.95% 25.92% 19.70% 20.71%
Return on Equity Simple (ROE_SIMPLE)
34.04% 0.00% 26.01% 22.97% 20.64% 0.00% 16.79% 18.15% 17.68% 0.00%
Net Operating Profit after Tax (NOPAT)
188 147 80 116 128 104 68 179 140 148
NOPAT Margin
22.71% 20.09% 12.94% 16.99% 18.17% 15.52% 11.42% 24.47% 19.03% 19.70%
Net Nonoperating Expense Percent (NNEP)
-0.41% 2.15% 0.38% 0.47% 0.03% 1.35% -0.50% 0.81% 0.53% -0.19%
Return On Investment Capital (ROIC_SIMPLE)
- 5.88% - - - 4.12% - - - 5.26%
Cost of Revenue to Revenue
41.31% 42.55% 42.28% 41.19% 43.40% 43.40% 43.44% 41.66% 40.80% 40.59%
SG&A Expenses to Revenue
16.40% 19.51% 24.45% 21.29% 19.66% 21.23% 24.87% 21.16% 21.38% 20.69%
R&D to Revenue
13.51% 14.87% 17.13% 15.44% 14.84% 15.24% 17.21% 15.32% 15.93% 17.05%
Operating Expenses to Revenue
30.70% 34.69% 42.68% 38.37% 36.14% 38.06% 43.60% 29.52% 38.58% 39.01%
Earnings before Interest and Taxes (EBIT)
226 193 93 139 138 132 66 214 155 153
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
254 195 120 166 167 160 94 244 185 180
Valuation Ratios
- - - - - - - - - -
Price to Book Value (P/BV)
5.19 5.50 6.81 7.06 6.31 6.53 6.74 8.48 7.57 7.27
Price to Tangible Book Value (P/TBV)
6.42 6.76 8.38 8.69 7.70 7.95 8.13 10.06 8.92 8.51
Price to Revenue (P/Rev)
3.53 4.27 5.53 6.01 5.63 6.17 6.48 8.56 8.03 7.26
Price to Earnings (P/E)
15.24 18.83 26.19 30.73 30.57 36.78 40.13 46.71 42.81 37.77
Dividend Yield
0.58% 0.51% 0.41% 0.40% 0.44% 0.41% 0.40% 0.31% 0.35% 0.38%
Earnings Yield
6.56% 5.31% 3.82% 3.25% 3.27% 2.72% 2.49% 2.14% 2.34% 2.65%
Enterprise Value to Invested Capital (EV/IC)
7.59 8.37 9.76 9.92 8.89 9.96 9.86 13.59 12.31 12.03
Enterprise Value to Revenue (EV/Rev)
3.29 3.97 5.26 5.73 5.34 5.82 6.16 8.15 7.58 6.83
Enterprise Value to EBITDA (EV/EBITDA)
10.71 13.57 18.44 21.55 21.68 25.40 27.91 33.19 30.39 27.40
Enterprise Value to EBIT (EV/EBIT)
12.05 14.95 21.15 25.23 25.95 31.01 34.46 40.07 36.64 32.77
Enterprise Value to NOPAT (EV/NOPAT)
13.84 17.68 25.51 30.82 31.00 36.39 39.32 46.07 42.26 35.96
Enterprise Value to Operating Cash Flow (EV/OCF)
14.98 21.67 26.90 26.59 28.11 26.60 28.55 34.09 32.51 28.66
Enterprise Value to Free Cash Flow (EV/FCFF)
18.44 32.59 43.59 45.97 56.47 43.16 42.86 43.17 46.23 38.68
Leverage & Solvency
- - - - - - - - - -
Debt to Equity
0.03 0.02 0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to Equity
0.02 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage
-0.44 -0.47 -0.39 -0.34 -0.34 -0.39 -0.34 -0.37 -0.38 -0.41
Leverage Ratio
1.48 1.46 1.42 1.45 1.42 1.40 1.36 1.36 1.34 1.35
Compound Leverage Factor
1.48 1.48 1.49 1.51 1.49 1.49 1.51 1.39 1.37 1.39
Debt to Total Capital
2.79% 2.00% 1.41% 1.33% 0.95% 0.00% 0.00% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital
0.63% 2.00% 1.41% 1.33% 0.95% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
2.16% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
97.21% 98.00% 98.59% 98.67% 99.05% 100.00% 100.00% 100.00% 100.00% 100.00%
Debt to EBITDA
0.06 0.05 0.04 0.04 0.03 0.00 0.00 0.00 0.00 0.00
Net Debt to EBITDA
-0.81 -1.03 -0.96 -1.02 -1.18 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to EBITDA
0.05 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT
0.08 0.07 0.06 0.06 0.05 0.00 0.00 0.00 0.00 0.00
Net Debt to NOPAT
-1.05 -1.35 -1.33 -1.47 -1.69 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to NOPAT
0.06 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score
8.56 9.59 12.52 12.51 11.69 12.00 13.80 17.07 16.83 15.47
Noncontrolling Interest Sharing Ratio
0.06% 0.03% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - -
Current Ratio
3.03 3.03 3.36 3.17 3.28 3.28 3.73 2.80 3.09 2.91
Quick Ratio
1.86 1.86 1.91 1.79 1.83 1.88 2.12 1.49 1.74 1.71
Cash Flow Metrics
- - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-8.17 -177 -178 -59 -85 37 34 211 98 111
Operating Cash Flow to CapEx
697.69% 530.42% 46.66% 363.67% 503.83% 561.12% 16.53% 37.94% 306.50% 452.92%
Free Cash Flow to Firm to Interest Expense
-10.48 -174.52 -180.32 -56.58 -87.98 45.63 51.52 137.73 121.47 188.17
Operating Cash Flow to Interest Expense
348.66 180.69 19.59 136.62 181.05 306.76 11.01 141.22 205.78 480.54
Operating Cash Flow Less CapEx to Interest Expense
298.68 146.63 -22.40 99.05 145.11 252.09 -55.59 -231.00 138.64 374.44
Efficiency Ratios
- - - - - - - - - -
Asset Turnover
0.93 0.86 0.86 0.83 0.82 0.77 0.78 0.77 0.77 0.78
Accounts Receivable Turnover
5.87 6.06 6.02 4.86 5.55 5.86 6.03 5.61 5.82 6.31
Inventory Turnover
4.99 4.53 4.08 3.72 3.66 3.59 3.42 3.65 3.73 3.85
Fixed Asset Turnover
8.21 7.83 7.25 6.74 6.43 6.19 5.98 5.95 5.90 5.91
Accounts Payable Turnover
8.27 8.80 8.36 7.28 6.74 7.13 7.69 7.40 6.91 7.44
Days Sales Outstanding (DSO)
62.20 60.27 60.62 75.08 65.75 62.28 60.52 65.03 62.68 57.83
Days Inventory Outstanding (DIO)
73.16 80.54 89.37 98.09 99.66 101.69 106.76 99.98 97.84 94.83
Days Payable Outstanding (DPO)
44.16 41.50 43.69 50.16 54.14 51.22 47.47 49.35 52.80 49.08
Cash Conversion Cycle (CCC)
91.20 99.31 106.30 123.01 111.27 112.75 119.81 115.66 107.72 103.58
Capital & Investment Metrics
- - - - - - - - - -
Invested Capital
1,432 1,496 1,626 1,655 1,644 1,563 1,660 1,622 1,687 1,601
Invested Capital Turnover
2.48 2.36 2.02 1.83 1.78 1.75 1.62 1.65 1.64 1.78
Increase / (Decrease) in Invested Capital
196 324 258 175 213 67 34 -32 42 38
Enterprise Value (EV)
10,871 12,521 15,863 16,407 14,611 15,568 16,364 22,041 20,754 19,267
Market Capitalization
11,693 13,476 16,687 17,187 15,408 16,505 17,234 23,150 21,970 20,486
Book Value per Share
$14.38 $15.74 $15.70 $15.71 $15.85 $16.52 $16.71 $17.49 $17.79 $17.31
Tangible Book Value per Share
$11.63 $12.81 $12.76 $12.76 $12.99 $13.57 $13.85 $14.73 $15.09 $14.79
Total Capital
2,319 2,501 2,485 2,468 2,465 2,526 2,558 2,731 2,903 2,819
Total Debt
65 50 35 33 24 0.00 0.00 0.00 0.00 0.00
Total Long-Term Debt
50 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt
-822 -955 -824 -780 -797 -937 -871 -1,108 -1,216 -1,218
Capital Expenditures (CapEx)
39 35 41 39 35 44 44 569 54 62
Debt-free, Cash-free Net Working Capital (DFCFNWC)
664 667 777 778 766 682 762 669 692 592
Debt-free Net Working Capital (DFNWC)
1,440 1,562 1,519 1,487 1,482 1,502 1,511 1,130 1,244 1,192
Net Working Capital (NWC)
1,426 1,512 1,484 1,454 1,459 1,502 1,511 1,130 1,244 1,192
Net Nonoperating Expense (NNE)
4.31 -25 -3.63 -3.74 -0.27 -13 4.29 -7.67 -5.31 2.07
Net Nonoperating Obligations (NNO)
-822 -955 -824 -780 -797 -963 -898 -1,108 -1,216 -1,218
Total Depreciation and Amortization (D&A)
28 2.18 28 27 28 28 28 30 31 27
Debt-free, Cash-free Net Working Capital to Revenue
20.08% 21.15% 25.75% 27.21% 27.97% 25.50% 28.67% 24.76% 25.29% 21.00%
Debt-free Net Working Capital to Revenue
43.53% 49.50% 50.34% 51.97% 54.14% 56.13% 56.84% 41.79% 45.44% 42.26%
Net Working Capital to Revenue
43.09% 47.91% 49.18% 50.83% 53.29% 56.13% 56.84% 41.79% 45.44% 42.26%
Earnings Adjustments
- - - - - - - - - -
Adjusted Basic Earnings per Share
$1.17 $1.11 $0.54 $0.78 $0.83 $0.76 $0.42 $1.18 $0.89 $0.92
Adjusted Weighted Average Basic Shares Outstanding
156.36M 158.43M 155.90M 154.76M 153.76M 154.31M 153.05M 157.80M 163.00M 159.08M
Adjusted Diluted Earnings per Share
$1.10 $1.04 $0.50 $0.73 $0.78 $0.72 $0.40 $1.14 $0.89 $0.89
Adjusted Weighted Average Diluted Shares Outstanding
166.73M 169.73M 166.31M 164.75M 164.05M 164.30M 162.35M 163.47M 164.25M 163.31M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
155.76M 156.05M 155.04M 154.01M 152.88M 153.08M 156.11M 163.18M 162.86M 161.72M
Normalized Net Operating Profit after Tax (NOPAT)
189 145 82 122 134 109 72 180 145 153
Normalized NOPAT Margin
22.88% 19.80% 13.22% 17.77% 19.03% 16.27% 12.07% 24.70% 19.61% 20.28%
Pre Tax Income Margin
27.35% 26.68% 15.72% 21.10% 20.50% 20.85% 12.15% 30.06% 21.56% 20.96%
Debt Service Ratios
- - - - - - - - - -
EBIT to Interest Expense
289.68 190.00 94.04 133.10 143.69 162.46 99.39 140.01 191.48 260.67
NOPAT to Interest Expense
241.07 144.84 80.95 111.31 132.75 128.35 103.61 116.73 173.69 252.25
EBIT Less CapEx to Interest Expense
239.70 155.93 52.05 95.54 107.75 107.79 32.79 -232.21 124.34 154.57
NOPAT Less CapEx to Interest Expense
191.10 110.78 38.96 73.74 96.82 73.68 37.01 -255.49 106.55 146.15
Payout Ratios
- - - - - - - - - -
Dividend Payout Ratio
8.97% 9.74% 10.83% 12.24% 13.53% 15.13% 16.09% 14.34% 14.37% 14.09%
Augmented Payout Ratio
131.99% 114.86% 111.90% 92.17% 82.70% 103.65% 92.02% 54.63% 34.99% 50.70%

Frequently Asked Questions About Teradyne's Financials

When does Teradyne's fiscal year end?

According to the most recent income statement we have on file, Teradyne's financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has Teradyne's net income changed over the last 9 years?

Teradyne's net income appears to be on an upward trend, with a most recent value of $542.37 million in 2024, rising from $206.48 million in 2015. The previous period was $448.75 million in 2023.

What is Teradyne's operating income?
Teradyne's total operating income in 2024 was $593.79 million, based on the following breakdown:
  • Total Gross Profit: $1.65 billion
  • Total Operating Expenses: $1.06 billion
How has Teradyne revenue changed over the last 9 years?

Over the last 9 years, Teradyne's total revenue changed from $1.64 billion in 2015 to $2.82 billion in 2024, a change of 72.0%.

How much debt does Teradyne have?

Teradyne's total liabilities were at $889.42 million at the end of 2024, a 7.4% decrease from 2023, and a 52.6% increase since 2015.

How much cash does Teradyne have?

In the past 9 years, Teradyne's cash and equivalents has ranged from $264.71 million in 2015 to $1.12 billion in 2021, and is currently $553.35 million as of their latest financial filing in 2024.

How has Teradyne's book value per share changed over the last 9 years?

Over the last 9 years, Teradyne's book value per share changed from 9.57 in 2015 to 17.31 in 2024, a change of 81.0%.

Remove Ads


This page (NASDAQ:TER) was last updated on 4/15/2025 by MarketBeat.com Staff
From Our Partners